Search Results - "Magilavy, Daniel B"

Refine Results
  1. 1

    An Oral Spleen Tyrosine Kinase (Syk) Inhibitor for Rheumatoid Arthritis by Weinblatt, Michael E, Kavanaugh, Arthur, Genovese, Mark C, Musser, Theresa K, Grossbard, Elliott B, Magilavy, Daniel B

    Published in The New England journal of medicine (30-09-2010)
    “…Spleen tyrosine kinase (Syk) is an important modulator of immune signaling. In this randomized trial involving patients with active rheumatoid arthritis, there…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Hylan G-F 20 improves hip osteoarthritis: a prospective, randomized study by Spitzer, Andrew I, Bockow, Barry I, Brander, Victoria A, Yates, James W, MacCarter, Daryl K, Gudger, Garland K, Haller, Stephanie, Lake, Stephen L, Magilavy, Daniel B

    Published in The Physician and sportsmedicine (01-06-2010)
    “…We compared the efficacy and safety of intra-articular hylan G-F 20 with methylprednisolone acetate (MPA) for treating symptomatic Kellgren-Lawrence grade…”
    Get more information
    Journal Article
  6. 6
  7. 7

    Spleen Tyrosine Kinase (Syk) Inhibitor for Rheumatoid Arthritis by Otón, Teresa, Silva-Fernández, Lucía, Andreu, José Luis, Okamoto, Hiroshi, Kobayashi, Akiko, Weinblatt, Michael E, Grossbard, Elliot B, Magilavy, Daniel B

    Published in The New England journal of medicine (06-01-2011)
    “…To the Editor: Weinblatt et al. (Sept. 30 issue) 1 report on the safety and efficacy of an oral spleen tyrosine kinase (Syk) inhibitor in active rheumatoid…”
    Get full text
    Journal Article
  8. 8

    Effects of methotrexate on radiologic progression in juvenile rheumatoid arthritis by Harel, L, Wagner-Weiner, L, Poznanski, A K, Spencer, C H, Ekwo, E, Magilavy, D B

    Published in Arthritis and rheumatism (01-10-1993)
    “…To assess the effects of methotrexate (MTX) therapy on radiologic progression in juvenile rheumatoid arthritis (JRA). We evaluated serial wrist radiographs for…”
    Get more information
    Journal Article
  9. 9

    Intermittent intravenous cyclophosphamide therapy for lupus nephritis by Lehman, T J, Sherry, D D, Wagner-Weiner, L, McCurdy, D K, Emery, H M, Magilavy, D B, Kovalesky, A

    Published in The Journal of pediatrics (01-06-1989)
    “…We carried out a preliminary study to determine whether intermittent intravenous cyclophosphamide therapy could be safely and effectively used in the treatment…”
    Get more information
    Journal Article
  10. 10

    Animal models of chronic inflammatory arthritis by Magilavy, D B

    Published in Clinical orthopaedics and related research (01-10-1990)
    “…The use of animals has been indispensable to the investigation of the etiology, pathophysiology, and treatment of juvenile arthritis. Because of ethical…”
    Get more information
    Journal Article
  11. 11

    Liver of MRL/lpr mice contain interleukin-4-producing lymphocytes and accessory cells that support the proliferation of Th2 helper T lymphocyte clones by Magilavy, D B, Foys, K M, Gajewski, T F

    Published in European journal of immunology (01-09-1992)
    “…Hepatic nonparenchymal cells (NPC) from mice of nonautoimmune strains support the proliferation of only Th1 and not Th2 helper T lymphocyte (HTL) clones…”
    Get more information
    Journal Article
  12. 12

    The liver of MRL/lpr mice contains defective accessory cells and a population of immunosuppressive lymphocytes by Magilavy, D B, Rowley, D A, Davis, M

    Published in Cellular immunology (01-02-1990)
    “…Immunoregulatory abnormalities in the MRL/lpr mouse strain include activation of macrophages and hepatic natural killer cells, spontaneous production of tumor…”
    Get more information
    Journal Article
  13. 13

    Lymphocyte Ecto-5′-Nucleotidase Deficiency in Agammaglobulinemia by Edwards, N. Lawrence, Magilavy, Daniel B., Cassidy, James T., Fox, Irving H.

    “…Fresh peripheral blood lymphocytes from eight patients with congenital agammaglobulinemia demonstrate reduced ecto-5′-nucleotidase activity when compared to…”
    Get full text
    Journal Article
  14. 14

    High hepatic natural killer cell activity in murine lupus by MAGILAVY, D. B, STEINBERG, A. D, LATTA, S. L

    Published in The Journal of experimental medicine (01-07-1987)
    “…This study demonstrates a profound elevation of NK activity, as measured by cytotoxicity to YAC-1 targets in a 4-h incubation 51Cr-release assay, of freshly…”
    Get full text
    Journal Article
  15. 15

    Immune abnormalities in the pathogenesis of juvenile rheumatoid arthritis by Lipnick, R N, Tsokos, G C, Magilavy, D B

    “…Juvenile rheumatoid arthritis (JRA) is the most common rheumatic disease of childhood. Although the etiology remains unknown, immunoregulatory imbalances are…”
    Get more information
    Journal Article
  16. 16
  17. 17
  18. 18

    Pediatric rheumatology manpower and training: planning for the 1990s by LEHMAN, T. J. A, MAGILAVY, D. V, WARREN, R

    Published in Pediatrics (Evanston) (01-09-1989)
    “…According to recent estimates, 350 000 children each year will experience an acute episode of joint pain, and nearly 200 000 will have juvenile rheumatoid…”
    Get full text
    Journal Article
  19. 19

    Mucocutaneous lymph node syndrome: report of two cases complicated by gallbladder hydrops and diagnosed by ultrasound by Magilavy, D B, Speert, D P, Silver, T M, Sullivan, D B

    Published in Pediatrics (Evanston) (01-05-1978)
    “…Two patients with mucocutaneous lymph node syndrome are presented. During the course of their illnesses, they developed acute abdominal pain secondary to…”
    Get full text
    Journal Article
  20. 20

    A syndrome of childhood polyarteritis by Magilavy, D B, Petty, R E, Cassidy, J T, Sullivan, D B

    Published in The Journal of pediatrics (01-07-1977)
    “…In this report the clinical, laboratory, and histopathologic findings of nine children with polyarteritis are reviewed. All have had evidence of systemic…”
    Get more information
    Journal Article